-The Business Standard The new price caps for 191 essential drugs are likely to introduce serious distortions in the market for these medicines The National Pharmaceutical Pricing Authority, or NPPA, has announced new price caps for 191 essential drugs that are 10 to 50 per cent lower than the current prices. Drug makers have 45 days to recall the earlier batches and send out new ones with the lower price tags. This...
More »SEARCH RESULT
Total Matching Records found : 2106
Onion prices at two and a half year high
-PTI NEW DELHI: Onion prices jumped to two and a half year high of Rs 24 per kg due to tight supply and strong Ramzan demand. Wholesale rates at Maharashtra's Lasalgoan, the Asia's biggest wholesale market for onion, soared almost five times higher than levels at the same time last year, stoking fears of retail prices rocketing across the country. Retail prices of onion in Delhi ranged between Rs 30 and 35 per...
More »Five questions govt needs to answer on food security -Vivek Kaul
-First Post Sonia Gandhi wants the chief ministers of fourteen states in which the Congress party is in power to role out the food security scheme in letter and spirit, and in quick time. Some media reports suggest that the scheme will be rolled out on August 20, which also happens to be the birth anniversary of Sonia's late husband Rajiv Gandhi. While there seems to be a great hurry to launch...
More »Eco concerns delay river-bed mining -Manpreet Randhawa
-The Hindustan Times Chandigarh: Ecological issues have delayed the start of river-bed mining, an idea propagated by Punjab deputy chief minister Sukhbir Singh Badal with the aim of extracting enough sand not only to meet the growing demand but also to control its skyrocketing rates in the market. The plan may not be implemented immediately as the proposed quarries would require clearance from the state environment impact assessment authority. Also, environmentalists fear...
More »SMS, RTI potent tools of drug companies fighting patent battle -Soma Das
-The Economic Times NEW DELHI: As patent wars heat up in the pharma space, mobile phone messages and Right to Information filings have emerged as potent weapons in the hands of multinationals keen to delay competition from low-cost generic versions of their patented products in India. Innovator drugmakers, who used to strike with patent suits after generic drugmakers released their versions in the market, have started gleaning information from text messages sent...
More »
